2-aminoalcohols for the treatment of neurodegenerative diseases

Details for Australian Patent Application No. 2006293671 (hide)

Owner Biocopea Limited

Inventors Bannister, Robin Mark; Lyne, Michael Harvey

Agent Madderns

Pub. Number AU-B-2006293671

PCT Pub. Number WO2007/034200

Priority 0519274.5 21.09.05 GB

Filing date 21 September 2006

Wipo publication date 29 March 2007

Acceptance publication date 1 July 2010

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/034200 Priority application(s): WO2007/034200

1 April 2010 Assignment before Grant

  Sosei R & D Ltd. The application has been assigned to Biocopea Limited

1 July 2010 Application Accepted

  Published as AU-B-2006293671

28 October 2010 Standard Patent Sealed

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006293674-A device

2006293667-Imaging agents comprising silicon